Oldest pages
Showing below up to 50 results in range #1,301 to #1,350.
- 34. Intravascular radiologic interventions II. Interventional radiologic treatment of bleeding, vasoocclusive techniques (embolization, sclerotisation). (21:03, 4 January 2024)
- 35. Image-guided biopsies. Cyst puncture, drainage (biliary, renal, bladder etc.) (21:03, 4 January 2024)
- 36. Radiologic interventions in tumor treatment (Tumor ablation techniques. Selective cytostatic treatment, chemoembolization). (21:04, 4 January 2024)
- 37. The fundamentals of nuclear medicine imaging. Types of radiation, applications. (21:05, 4 January 2024)
- 38. Advantages of hybrid techniques (SPECT/CT, PET/CT). (21:06, 4 January 2024)
- 39. Radioisotope diagnostics of pulmonary embolism (perfusion and inhalation). Radioisotope methods in pulmonary malignancies. (21:06, 4 January 2024)
- 40. Radioisotope examination of myocardial perfusion (transient and permanent ischaemia, viability). Radioisotope examination of left ventricle pump function and wall motion problems. (21:07, 4 January 2024)
- 41. Radioisotope diagnostics of thyroid diseases and parathyroid diseases. (21:07, 4 January 2024)
- 42. Nuclear medicine methods in childhood (kidney, bone, 123I-MIBG scintigraphy). (21:07, 4 January 2024)
- 43. Radioisotope diagnostics in breast and gynecologic tumors. The significance of sentinel lymph node scintigraphy. (21:08, 4 January 2024)
- 44. Brain perfusion examinations in nuclear medicine (indications, radiopharmaceuticals, imaging). (21:08, 4 January 2024)
- 45. Nuclear medicine examinations in gastroenterology. (21:08, 4 January 2024)
- 47. Indications of bone scintigraphy. The significance and indications of 3-phase bone scintigraphy. (21:09, 4 January 2024)
- 48. Radioiodine therapy in the diseases of the thyroid gland. (21:09, 4 January 2024)
- 49. Radionuclide therapy of neuroendocrine and neuroectodermal tumors. (21:10, 4 January 2024)
- 62. General characteristics and types of chronic obstructive lung diseases (19:35, 12 January 2024)
- 1. Pentose phosphate pathway (16:47, 15 January 2024)
- Obesity (16:53, 15 January 2024)
- 1. Importance of non-communicable diseases in developed countries (mortality, morbidity, trends) (16:55, 15 January 2024)
- Purpose of investigation (11:58, 16 January 2024)
- Screening (11:58, 16 January 2024)
- 1. Purpose of laboratory test requests (screening, diagnosis, differential-diagnosis, validation, monitoring). (11:59, 16 January 2024)
- 2. Patient preparation before sampling. Proper method to carry out blood (venous, capillary) and urine collection. Type of tubes. (12:11, 16 January 2024)
- 3. Reference values and ranges, specificity, sensitivity and predictive value of laboratory tests. (12:14, 16 January 2024)
- 11. Risk factors of malignant diseases (13:06, 16 January 2024)
- 25. Epidemiology and prevention of ulcer disease (13:08, 16 January 2024)
- Test characteristics (13:45, 16 January 2024)
- 12. Screening of malignant diseases (14:12, 18 January 2024)
- Point of care test (14:46, 18 January 2024)
- 5. Bedside/point of care tests (POCT) and their informational value (14:46, 18 January 2024)
- 31. Pathogenesis and clinicopathology of tuberculosis (21:49, 25 January 2024)
- Sodium (20:51, 28 January 2024)
- 6. Disorders of water and sodium homeostasis (20:53, 28 January 2024)
- Hyponatraemia (20:26, 30 January 2024)
- Hypernatraemia (20:35, 30 January 2024)
- Potassium (21:13, 31 January 2024)
- Hypokalaemia (21:23, 31 January 2024)
- 7. Disorders of potassium balance (21:24, 31 January 2024)
- Hyperkalaemia (21:29, 31 January 2024)
- 20. Nosocomial infections. Sterilization, disinfection (20:22, 19 February 2024)
- Ventricular arrhythmia (17:39, 20 February 2024)
- Hypoventilation (21:05, 28 February 2024)
- Respiratory failure (21:09, 29 February 2024)
- 8. Laboratory findings in metabolic type changes of the acid/base balance (22:00, 29 February 2024)
- 9. Laboratory findings in respiratory type changes of the acid/base balance (20:06, 1 March 2024)
- Hypocalcaemia (15:44, 4 March 2024)
- Hypercalcaemia (16:40, 4 March 2024)
- Hepatitis E (22:47, 15 March 2024)
- Thoracic empyema (21:04, 18 March 2024)
- B7. Prenatal diagnostics I. (invasive methods) (19:05, 21 March 2024)